Lupeol inhibits osteosarcoma progression by up-regulation of HMGA2 via regulating miR-212-3p

BACKGROUND: Osteosarcoma (OS) is a common severe illness globally. Lupeol has been reported to participate in the pathophysiologic properties of various cancers, including OS. This study aimed to explore the effects of lupeol on proliferation, invasion, and apoptosis on OS cells and the underlying m...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Jinghua, He, Chunlei, Xu, Fangtian, Xu, Xianyun, Liu, Lulin, Xu, Mingjun, Guo, Zheng, Wang, Yili, Liao, Jiahua, Li, Yonghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469105/
https://www.ncbi.nlm.nih.gov/pubmed/32883329
http://dx.doi.org/10.1186/s13018-020-01879-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469105/
https://www.ncbi.nlm.nih.gov/pubmed/32883329
http://dx.doi.org/10.1186/s13018-020-01879-0

Ejemplares similares